Ignite Planners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.55M Buy
1,690
+19
+1% +$19.3K 0.24% 103
2025
Q4
$1.73M Sell
1,671
-191
-10% -$183K 0.27% 89
2025
Q3
$1.42M Sell
1,862
-10
-0.5% -$7.44K 0.23% 106
2025
Q2
$1.45M Sell
1,872
-126
-6% -$97.9K 0.25% 101
2025
Q1
$1.59M Buy
1,998
+71
+4% +$59.1K 0.31% 83
2024
Q4
$1.51M Sell
1,927
-21
-1% -$17.4K 0.33% 71
2024
Q3
$1.73M Sell
1,948
-19
-1% -$17.1K 0.4% 65
2024
Q2
$1.8M Buy
1,967
+4
+0.2% +$3.2K 0.44% 62
2024
Q1
$1.49M Buy
1,963
+15
+0.8% +$10.7K 0.42% 69
2023
Q4
$1.15M Sell
1,948
-82
-4% -$47.9K 0.34% 78
2023
Q3
$1.1M Buy
2,030
+7
+0.3% +$3.61K 0.34% 78
2023
Q2
$915K Buy
2,023
+871
+76% +$365K 0.35% 66
2023
Q1
$423K Sell
1,152
-217
-16% -$73.2K 0.17% 148
2022
Q4
$468K Buy
1,369
+8
+0.6% +$2.84K 0.2% 133
2022
Q3
$438K Buy
1,361
+24
+2% +$7.6K 0.35% 90
2022
Q2
$438K Buy
1,337
+62
+5% +$18.6K 0.36% 87
2022
Q1
$355K Buy
1,275
+232
+22% +$59.7K 0.24% 122
2021
Q4
$258K Buy
+1,043
New +$264K 0.17% 146

Other funds holding LLY

Ignite Planners's LLY Position: Q1 2026 in Review

Ignite Planners increased its Eli Lilly (LLY) stake by 1.1% in Q1 2026, buying an estimated $19.3K and bringing the position to 1,690 shares worth $1.55M. The position accounts for 0.24% of the portfolio, ranked #103.

Ignite Planners first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.8M in Q2 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Ignite Planners held 1,690 shares of Eli Lilly worth $1.55M as of Q1 2026.
  • Ignite Planners bought 19 Eli Lilly shares in Q1 2026, an estimated $19.3K.
  • Eli Lilly made up 0.24% of Ignite Planners's portfolio in Q1 2026, its #103 holding.
  • Ignite Planners first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
  • Ignite Planners's Eli Lilly position peaked at $1.8M in Q2 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Ignite Planners's 13F filing for Q1 2026, filed 17 Apr 2026.